Polomar Health Services, Inc.
PMHS
$0.20
-$0.2216-52.56%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -39.16% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -39.16% | -- | -- | -- | |
| Cost of Revenue | -15.96% | -- | -- | -- | |
| Gross Profit | -47.92% | -- | -- | -- | |
| SG&A Expenses | 210.63% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 204.05% | -- | -- | -- | |
| Operating Income | -232.01% | -- | -- | -- | |
| Income Before Tax | -182.11% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -182.11% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -182.11% | -- | -- | -- | |
| EBIT | -232.01% | -- | -- | -- | |
| EBITDA | -32.67% | -- | -- | -- | |
| EPS Basic | -161.27% | -- | -- | -- | |
| Normalized Basic EPS | -161.58% | -- | -- | -- | |
| EPS Diluted | -166.55% | -- | -- | -- | |
| Normalized Diluted EPS | -161.58% | -- | -- | -- | |
| Average Basic Shares Outstanding | 5.92% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 5.92% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |